Vascular Cell

unofficial impact factor 2.22

Open Access Review

Clinical trials with anti-angiogenic agents in hematological malignancies

Michael Medinger and Klaus Mross*

Journal of Angiogenesis Research 2010, 2:10 doi:10.1186/2040-2384-2-10

No comments have yet been made on this article.

Post a comment